Skip to main content Accessibility help
×
Home

Influence of gestational age on serum incretin levels in preterm infants

  • H. Shoji (a1), A. Watanabe (a2), N. Ikeda (a2), M. Mori (a2), T. Kitamura (a2), K. Hisata (a2) and T. Shimizu (a1)...

Abstract

Glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) are the incretin hormones secreted from the intestine in response to enteral feeding to stimulate insulin secretion. We investigated the relationship serum GIP and GLP-1 levels with gestational age, and insulin secretion in preterm infants. Serum GIP and GLP-1 levels were measured at birth and at 1, 2 and 4 weeks after birth in 30 infants, including 12 born before 30th week of gestation (early group) and 18 born after 30th week of gestation (late group). Blood glucose and serum insulin levels were measured, and the quantitative insulin sensitivity check index (QUICKI) was also calculated. The levels of GLP-1 at 2 and 4 weeks were significantly higher in the early group than those in the late group. The levels of GIP were not significantly different between two groups. At 4 weeks, serum insulin level was significantly higher and QUICKI was significantly lower in the early group. Furthermore, GLP-1 levels were significantly correlated with QUICKI and the serum insulin levels in all infants at 4 weeks. In preterm infants, enteral feeding to premature intestine may be associated with GLP-1 secretion. GLP-1 is also related to stimulated insulin secretion in early postnatal period.

Copyright

Corresponding author

*Address for correspondence: H. Shoji, Department of Pediatrics and Adolescent Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan. (Email hshoji@juntendo.ac.jp)

References

Hide All
1. Itabashi, K, Horiuchi, T, Kusuda, S, et al. Mortality rates for extremely low birth weight infants born in Japan in 2005. Pediatrics. 2009; 123, 445450.
2. Singhal, A, Farooqi, IS, O’Rahilly, S, et al. Early nutrition and leptin concentrations in later life. Am J Clin Nutr. 2002; 75, 993999.
3. Singhal, A, Fewtrell, M, Cole, TJ, Lucas, A. Low nutrient intake and early growth for later insulin resistance in adolescents born preterm. Lancet. 2003; 361, 10891097.
4. Ten, S, Maclaren, N. Insulin resistance syndrome in children. J Clin Endocrinol Metab. 2004; 89, 25262539.
5. Baggio, LL, Drucker, DJ. Biology of incretins: GLP-1 and GIP. Gastroenterology. 2007; 132, 21312157.
6. Ambati, S, Duan, J, Hartzell, DL, et al. GIP-dependent expression of hypothalamic genes. Physiol Res. 2011; 60, 941950.
7. Kawamata, R, Suzuki, Y, Yada, Y, et al. Gut hormones of preterm infants with abdominal symptoms and hypothyroxinemia. Pediatr Int. 2015; 57, 614619.
8. Kawamata, R, Suzuki, Y, Yada, Y, et al. Gut hormone profiles in preterm and term infants during the first 2 months of life. J Pediatr Endocrinol Metab. 2014; 27, 717723.
9. Itabashi, K, Miura, F, Uehara, R, Nakamura, Y. New Japanese neonatal anthropometric charts for gestational age at birth. Pediatr Int. 2014; 56, 702708.
10. Padidela, R, Patterson, M, Sharief, N, Ghatei, M, Hussain, K. Elevated basal and post-feed glucagon-like peptide 1 (GLP-1) concentrations in the neonatal period. Eur J Endocrinol. 2009; 160, 5358.
11. Berseth, CL, Nordyke, CK, Valdes, MG, Furlow, BL, Go, VL. Responses of gastrointestinal peptides and motor activity to milk and water feedings in preterm and term infants. Pediatr Res. 1992; 31, 587590.
12. Detel, D, Baticic, L, Varljen, J. The influence of age on intestinal dipeptidyl peptidase IV (DPP IV/CD26), disaccharidases, and alkaline phosphatase enzyme activity in C57BL/6 mice. Exp Aging Res. 2008; 34, 4962.
13. Hvidberg, A, Nielsen, MT, Hilsted, J, Orskov, C, Holst, JJ. Effect of glucagon-like peptide-1 (proglucagon 78-107amide) on hepatic glucose production in healthy man. Metabolism. 1994; 43, 104108.
14. Buteau, J, Foisy, S, Rhodes, CJ, et al. Protein kinase Czeta activation mediates glucagon-like peptide-1-induced pancreatic beta-cell proliferation. Diabetes. 2001; 50, 22372243.
15. Buteau, J, Foisy, S, Joly, E, Prentki, M. Glucagon-like peptide 1 induces pancreatic beta-cell proliferation via transactivation of the epidermal growth factor receptor. Diabetes. 2003; 52, 124132.
16. Farilla, L, Hui, H, Bertolotto, C, et al. Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats. Endocrinology. 2002; 143, 43974408.
17. Flint, A, Raben, A, Astrup, A, Holst, JJ. Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. J Clin Invest. 1998; 101, 515520.
18. Small, CJ, Bloom, SR. Gut hormones and the control of appetite. Trends Endocrinol Metab. 2004; 15, 259263.
19. Lucas, A, Boyes, S, Bloom, SR, Aynsley-Green, A. Metabolic and endocrine responses to a milk feed in six-day-old term infants: differences between breast and cow’s milk formula feeding. Acta Paediatr Scand. 1981; 70, 195200.
20. Wang, G, Divall, S, Radovick, S, et al. Preterm birth and random plasma insulin levels at birth and in early childhood. JAMA. 2014; 311, 587596.

Keywords

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed